Abstract
The landscape of immune therapy in vulnerable patients with advanced non-small cell lung cancer: a narrative review
Full Text
Sign-in/Register to access full text options
Published version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have